NCT05813873

Brief Summary

The aim of this clinical trial is to investigate the efficacy of Triflow in the rehabilitation of patients with long covid syndrome hospitalised in a rehabilitation center. Participants will be divided into 2 groups and follow their exercise regime until the day they are discharged from the rehabilitation center. The intervention group will participate in a rehabilitation program which includes upper and lower limbs exercises, cycle ergometer, walking and the use of triflow. The control group will participate in the same program but without the Triflow.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Dec 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Dec 2022Dec 2026

Study Start

First participant enrolled

December 21, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 12, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 14, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

August 14, 2025

Status Verified

March 1, 2025

Enrollment Period

3 years

First QC Date

April 12, 2023

Last Update Submit

August 10, 2025

Conditions

Keywords

Triflow, Incentive Spirometry, Long-covid

Outcome Measures

Primary Outcomes (6)

  • Barthel Index

    Measures performance in activities of daily living (eg.stairs, dressing/undressing, washing,eating). Score from 0 to 100, where 0 indicates total dependence and 100 total independence with activities of daily living.

    on admission day

  • Barthel Index

    Measures performance in activities of daily living (eg.stairs, dressing/undressing, washing,eating). Score from 0 to 100, where 0 indicates total dependence and 100 total independence with activities of daily living.

    on discharge day

  • Dyspnoea (Medical Research Council Dyspnoea Scale)

    Assess dyspnoea via MRC dyspnoea scale. The participants grade their dyspnoea on a scale of 1 to 5. The bigger the number, the worse their dyspnoea is

    on admission day

  • Dyspnoea (Medical Research Council Dyspnoea Scale)

    Assess dyspnoea via MRC dyspnoea scale. The participants grade their dyspnoea on a scale of 1 to 5. The bigger the number, the worse their dyspnoea is

    on discharge day

  • Peak Flow Meter

    Assess the respiratory function via peak flow meter. The participants will take a deep breath and blow the air out into the peak flow meter. The higher the score the better their respiratory function is

    on admission day

  • Peak Flow Meter

    Assess the respiratory function via peak flow meter. The participants will take a deep breath and blow the air out into the peak flow meter. The higher the score the better their respiratory function is

    on discharge day

Secondary Outcomes (15)

  • Number of hospitalisation days

    on discharge day

  • Muscle strength (Hand Grip)

    on admission day

  • Muscle strength (Hand Grip)

    on discharge day

  • Muscle strength and endurance (30 seconds Sit to stand)

    on admission day

  • Muscle strength and endurance (30 seconds Sit to stand)

    on discharge day

  • +10 more secondary outcomes

Study Arms (2)

Triflow

EXPERIMENTAL

Use of Triflow device and exercise regime

Other: Triflow

Control

ACTIVE COMPARATOR

Only exercise regime

Other: Control

Interventions

TriflowOTHER

Triflow

Also known as: Triflow and exercise regime
Triflow
ControlOTHER

Exercise

Also known as: Exercise regime
Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults who were infected with COVID-19 in the last 6 months and were diagnosed with long-covid syndrome
  • Patients must be willing to give written consent for participation in the study
  • Negative rapid test for COVID-19

You may not qualify if:

  • History of diseases that do not allow exercise (e.g. unstable cardiac disease)
  • Age \< 18 years of age
  • Significant cognitive and psychiatric impairments (inability to follow simple commands or give consent)
  • Lack of will to do the exercises or refuse to give consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eden Resort Wellness Rehabilitation Center

Larnaca, 7562, Cyprus

Location

Related Publications (11)

  • Basoglu OK, Atasever A, Bacakoglu F. The efficacy of incentive spirometry in patients with COPD. Respirology. 2005 Jun;10(3):349-53. doi: 10.1111/j.1440-1843.2005.00716.x.

    PMID: 15955148BACKGROUND
  • Eltorai AEM, Szabo AL, Antoci V Jr, Ventetuolo CE, Elias JA, Daniels AH, Hess DR. Clinical Effectiveness of Incentive Spirometry for the Prevention of Postoperative Pulmonary Complications. Respir Care. 2018 Mar;63(3):347-352. doi: 10.4187/respcare.05679. Epub 2017 Dec 26.

    PMID: 29279365BACKGROUND
  • Imamura M, Mirisola AR, Ribeiro FQ, De Pretto LR, Alfieri FM, Delgado VR, Battistella LR. Rehabilitation of patients after COVID-19 recovery: An experience at the Physical and Rehabilitation Medicine Institute and Lucy Montoro Rehabilitation Institute. Clinics (Sao Paulo). 2021 Jun 14;76:e2804. doi: 10.6061/clinics/2021/e2804. eCollection 2021.

    PMID: 34133481BACKGROUND
  • Mohamed AA, Alawna M. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):489-496. doi: 10.1016/j.dsx.2020.04.038. Epub 2020 Apr 28.

    PMID: 32388326BACKGROUND
  • Seyller H, Gottlieb M, Colla J. A breath of fresh air: The role of incentive spirometry in the treatment of COVID-19. Am J Emerg Med. 2021 Oct;48:369. doi: 10.1016/j.ajem.2021.01.084. Epub 2021 Feb 1. No abstract available.

    PMID: 33558097BACKGROUND
  • Siddiq MAB, Rathore FA, Clegg D, Rasker JJ. Pulmonary Rehabilitation in COVID-19 patients: A scoping review of current practice and its application during the pandemic. Turk J Phys Med Rehabil. 2020 Nov 9;66(4):480-494. doi: 10.5606/tftrd.2020.6889. eCollection 2020 Dec.

    PMID: 33364571BACKGROUND
  • Spielmanns M, Pekacka-Egli AM, Schoendorf S, Windisch W, Hermann M. Effects of a Comprehensive Pulmonary Rehabilitation in Severe Post-COVID-19 Patients. Int J Environ Res Public Health. 2021 Mar 7;18(5):2695. doi: 10.3390/ijerph18052695.

    PMID: 33800094BACKGROUND
  • Zampogna E, Paneroni M, Belli S, Aliani M, Gandolfo A, Visca D, Bellanti MT, Ambrosino N, Vitacca M. Pulmonary Rehabilitation in Patients Recovering from COVID-19. Respiration. 2021;100(5):416-422. doi: 10.1159/000514387. Epub 2021 Mar 30.

    PMID: 33784696BACKGROUND
  • Franklin E, Anjum F. Incentive Spirometer and Inspiratory Muscle Training. 2023 Apr 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK572114/

    PMID: 34283480BACKGROUND
  • Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry: 2011. Respir Care. 2011 Oct;56(10):1600-4. doi: 10.4187/respcare.01471.

    PMID: 22008401BACKGROUND
  • Toor H, Kashyap S, Yau A, Simoni M, Farr S, Savla P, Kounang R, Miulli DE. Efficacy of Incentive Spirometer in Increasing Maximum Inspiratory Volume in an Out-Patient Setting. Cureus. 2021 Oct 4;13(10):e18483. doi: 10.7759/cureus.18483. eCollection 2021 Oct.

    PMID: 34754645BACKGROUND

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

COVID-19Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Marina Kloni

    European University Cyprus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Marina Eleni Kloni, BSc, MSc, MA

Study Record Dates

First Submitted

April 12, 2023

First Posted

April 14, 2023

Study Start

December 21, 2022

Primary Completion

December 23, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

August 14, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations